Prospects of combining adoptive cell immunotherapy with bortezomib

Immunotherapy. 2017 Mar;9(4):305-308. doi: 10.2217/imt-2017-0015.

Samuel T Pellom Jr^{1

2

3}, Ashutosh Singhal¹, Anil Shanker^{1

3

4

5

6}

¹ Department of Biochemistry & Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, USA.
² Department of Microbiology & Immunology, School of Medicine, Meharry Medical College, Nashville, TN, USA.
³ School of Graduate Studies & Research, Meharry Medical College, Nashville, TN, USA.
⁴ Host-Tumor Interactions Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, TN, USA.
⁵ Vanderbilt Center for Immunobiology, Vanderbilt University, Nashville, TN, USA.
⁶ Vanderbilt Center for Translational & Clinical Immunology, Vanderbilt University, Nashville, TN, USA.

No abstract available

Keywords: adoptive T-cell therapy; cancer immunology; cellular immunology.

Publication types